StockData
BSPKOTCPharmaceutical PreparationsFiscal year ends December 31

Bespoke Extracts, Inc.

Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 12, 2025
$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$5.62K
P/E (TTM)
–
Dividend yield
–

Bespoke Extracts, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Bespoke Extracts does not break out revenue by segment, region or product in the tagged data of its filings for this period type.